Global Optogenetics Market By Product Type(Lasers, Sensors, Actuators) By Application (Neuroscience, Behavioural Tracking, Retinal Disease Treatment, Others) By End Users ( Hospitals and Clinics, Diagnostics Centers, Research Centers, Others) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
In the last few years researchers are using optogenetic technology to stimulate, sense, and analyse function in cells, tissues, and organs in a spatiotemporally precise manner. Because of the transgenically expressed light gated cation channel, these techniques can provide low-energy and localised approaches. Optogenetics is a method of controlling and sensing genetically engineered neurons or proteins using light. Though the technology's origins date back decades, its use in the field of neurology was first demonstrated in 2002. While the field began with several neurological breakthroughs, it has also excelled in both in vitro and in vivo animal cardiac research. Implantable optical devices are being produced in large numbers to explore specific electrophysiological processes with the precision that optogenetics allows. Furthermore, government bodies across many countries are funding research organisations and individual researchers to introduce new technologies in neuroscience and ophthalmology, which is projected to drive the optogenetics market in the coming years. The expansion of optogenetics has been spurred by key initiatives conducted by international organisations such as the World Health Organization (WHO) and the National Institute of Health (NIH) in the field of mental health in diverse locations. Moreover, intact neural networks are currently being studied using developing technologies from optics, genetics, and bioengineering. Indeed, the rapid advancement of interdisciplinary "optogenetic" techniques has improved optical imaging and genetic targeting of specific cell types. Thus, with these advancements and initiatives the global optogenetics market is expected to flourish during the forecast period 2022-2030.
In terms of revenue, global optogenetics market was valued at US$ 524.5 Mn in 2021 growing at a CAGR of 3.96% over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Optogenetics Market Revenue & Forecast, (US$ Million), 2015 – 2030
Type Outlook
Based on the type, the global optogenetics market is segmented into lasers, sensors, actuators. Optogenetics actuators and sensors provide information about which biochemical and physiological pathways are active in a certain disease. This disease could be treated using procedures that involve shining blue light on certain brain cells. Advanced technology for delivering light to specific areas in biological tissues are critical for optogenetics research in neuroscience. In this context, fully implantable, tiny devices with wireless control and power-harvesting methodologies offer an enticing set of features, especially for research that are incompatible with traditional fiber-optic approaches or battery-powered head stages. Optogenetic technologies that are wireless, battery-free, and entirely subdermally implantable are poised to revolutionise neurological research. Sensors are expected to be the optogenetics market's fastest-growing category. Industrial entities are expected to make significant investments in genetically encoded calcium indicators, voltage-sensitive fluorescent proteins, and pH sensors, boosting segment growth. In addition, there are several active projects to build quick fluorescent voltage sensors. Scientists are working on building such sensors by improving Foster Resonance Energy Transfer (FRET) interactions, which can be used to monitor in vivo brain activity. Private and public entities are funding these investigations, which are projected to promote segment growth in the coming years.
Application Outlook
Based on the application outlook, the global optogenetics market is segmented into neuroscience, behavioural tracking, retinal disease treatment, cardiovascular research and others. There has been a huge demand for cardiovascular treatments due to the rise in the cardiovascular diseases amongst a huge population. Optogenetics for cardiovascular research is gaining huge importance due to the use of light which has been a longstanding tool in understanding healthy and abnormal cardiac electrical functioning. Furthermore, the advancements in optogenetics has the potential to be utilized as an arrhythmia termination therapy. Overall, optogenetic termination of arrhythmias has considerable potential for quick, precise, and controlled termination of ventricular arrhythmias due to the excellent spatial and temporal resolution of optogenetics. On the other hand, neurological diseases segment is being driven by an increase in the incidence of neurological and mental disorders such as Parkinson's disease, depression, and schizophrenia. Government organizations are encouraging various research and programs on optogenetics for neurology. For instance, Brain Canada granted 4 Million dollars for the Canadian Optogenetics and Vectorology Foundry, a network of research sites aimed at accelerating the development and distribution of optogenetic and viral tools. Thus, the rising awareness about the advantageous factors of optogenetics is contributing to growth of global optogenetics market.
Region Outlook
Based on the regions, North America had the highest share in the optogenetics market in the year 2021. Healthcare organisations along with government institutions are focused on investing into various clinical trials for optogenetics. Rising demand to study neuroscience has led to a huge demand for optogenetics amongst neurosurgeons and researchers for developing treatments for various diseases. Furthermore, the dominance of this region can be due to a number of factors, including the existence of local market participants, constant R&D, technical improvements, and a well-established healthcare system. Optogenetics market participants are looking forward to mergers and acquisitions for incorporating advanced technologies to expand their offering and their presence in the market. Thus these factors are contributing to the growth of optogenetics market in North American region.
Competitive Landscape
The report provides both, qualitative and quantitative research of global optogenetics market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global optogenetics market are
- Bruker
- Campden Instruments
- Coherent, Inc
- Elliot Scientific Ltd.
- Gensight Biologics
- Judges Scientific plc
- Merck KGaA
- Nanoscope Therapeutics, Inc.
- Noldus Information Technology
- Prizmatix
- Scientifica
- Thorlabs, Inc.
- Other Industry Participants
Global Optogenetics Market
By Product Type
- Lasers
- Sensors
- Actuators
By Application
- Neuroscience
- Behavioural Tracking
- Retinal Disease Treatment
- Others
By End Users
- Hospitals and Clinics
- Diagnostics Centers
- Research Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2020
1.2.2. Base Year: 2021
1.2.3. Forecast Years: 2022 - 2030
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Optogenetics Market
6.
Market
Synopsis: Optogenetics Market
7.
Optogenetics
Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in Optogenetics Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Optogenetics Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on Optogenetics Market
7.8. PESTEL Analysis
8.
Global
Optogenetics Market Analysis and Forecasts, 2022 - 2030
8.1. Overview
8.1.1. Global Optogenetics Market Revenue (US$ Mn)
8.2. Global Optogenetics Market Revenue (US$ Mn)
and Forecasts, By Product Type
8.2.1. Lasers
8.2.1.1.
Definition
8.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.1.3.
Market
Forecast, 2022 - 2030
8.2.1.4.
Compound
Annual Growth Rate (CAGR)
8.2.1.5.
Regional
Bifurcation
8.2.1.5.1.
North
America
8.2.1.5.1.1. Market Estimation, 2015 - 2021
8.2.1.5.1.2. Market Forecast, 2022 - 2030
8.2.1.5.2.
Europe
8.2.1.5.2.1. Market Estimation, 2015 - 2021
8.2.1.5.2.2. Market Forecast, 2022 - 2030
8.2.1.5.3.
Asia
Pacific
8.2.1.5.3.1. Market Estimation, 2015 - 2021
8.2.1.5.3.2. Market Forecast, 2022 - 2030
8.2.1.5.4.
Middle
East and Africa
8.2.1.5.4.1. Market Estimation, 2015 - 2021
8.2.1.5.4.2. Market Forecast, 2022 - 2030
8.2.1.5.5.
Latin
America
8.2.1.5.5.1. Market Estimation, 2015 - 2021
8.2.1.5.5.2. Market Forecast, 2022 - 2030
8.2.2. Sensors
8.2.2.1.
Definition
8.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.2.3.
Market
Forecast, 2022 - 2030
8.2.2.4.
Compound
Annual Growth Rate (CAGR)
8.2.2.5.
Regional
Bifurcation
8.2.2.5.1.
North
America
8.2.2.5.1.1. Market Estimation, 2015 - 2021
8.2.2.5.1.2. Market Forecast, 2022 - 2030
8.2.2.5.2.
Europe
8.2.2.5.2.1. Market Estimation, 2015 - 2021
8.2.2.5.2.2. Market Forecast, 2022 - 2030
8.2.2.5.3.
Asia
Pacific
8.2.2.5.3.1. Market Estimation, 2015 - 2021
8.2.2.5.3.2. Market Forecast, 2022 - 2030
8.2.2.5.4.
Middle
East and Africa
8.2.2.5.4.1. Market Estimation, 2015 - 2021
8.2.2.5.4.2. Market Forecast, 2022 - 2030
8.2.2.5.5.
Latin
America
8.2.2.5.5.1. Market Estimation, 2015 - 2021
8.2.2.5.5.2. Market Forecast, 2022 - 2030
8.2.3. Actuators
8.2.3.1.
Definition
8.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.3.3.
Market
Forecast, 2022 - 2030
8.2.3.4.
Compound
Annual Growth Rate (CAGR)
8.2.3.5.
Regional
Bifurcation
8.2.3.5.1.
North
America
8.2.3.5.1.1. Market Estimation, 2015 - 2021
8.2.3.5.1.2. Market Forecast, 2022 - 2030
8.2.3.5.2.
Europe
8.2.3.5.2.1. Market Estimation, 2015 - 2021
8.2.3.5.2.2. Market Forecast, 2022 - 2030
8.2.3.5.3.
Asia
Pacific
8.2.3.5.3.1. Market Estimation, 2015 - 2021
8.2.3.5.3.2. Market Forecast, 2022 - 2030
8.2.3.5.4.
Middle
East and Africa
8.2.3.5.4.1. Market Estimation, 2015 - 2021
8.2.3.5.4.2. Market Forecast, 2022 - 2030
8.2.3.5.5.
Latin America
8.2.3.5.5.1. Market Estimation, 2015 - 2021
8.2.3.5.5.2. Market Forecast, 2022 - 2030
8.3. Key Segment for Channeling Investments
8.3.1. By Product Type
9.
Global
Optogenetics Market Analysis and Forecasts, 2022 - 2030
9.1. Overview
9.2. Global Optogenetics Market Revenue (US$ Mn)
and Forecasts, By Application
9.2.1. Neuroscience
9.2.1.1.
Definition
9.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.1.3.
Market
Forecast, 2022 - 2030
9.2.1.4.
Compound
Annual Growth Rate (CAGR)
9.2.1.5.
Regional
Bifurcation
9.2.1.5.1.
North
America
9.2.1.5.1.1. Market Estimation, 2015 - 2021
9.2.1.5.1.2. Market Forecast, 2022 - 2030
9.2.1.5.2.
Europe
9.2.1.5.2.1. Market Estimation, 2015 - 2021
9.2.1.5.2.2. Market Forecast, 2022 - 2030
9.2.1.5.3.
Asia
Pacific
9.2.1.5.3.1. Market Estimation, 2015 - 2021
9.2.1.5.3.2. Market Forecast, 2022 - 2030
9.2.1.5.4.
Middle
East and Africa
9.2.1.5.4.1. Market Estimation, 2015 - 2021
9.2.1.5.4.2. Market Forecast, 2022 - 2030
9.2.1.5.5.
Latin
America
9.2.1.5.5.1. Market Estimation, 2015 - 2021
9.2.1.5.5.2. Market Forecast, 2022 - 2030
9.2.2. Behavioural Tracking
9.2.2.1.
Definition
9.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.2.3.
Market
Forecast, 2022 - 2030
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1. Market Estimation, 2015 - 2021
9.2.2.5.1.2. Market Forecast, 2022 - 2030
9.2.2.5.2.
Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2021
9.2.2.5.2.2. Market Forecast, 2022 - 2030
9.2.2.5.3.
Asia
Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2021
9.2.2.5.3.2. Market Forecast, 2022 - 2030
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2021
9.2.2.5.4.2. Market Forecast, 2022 - 2030
9.2.2.5.5.
Latin
America
9.2.2.5.5.1. Market Estimation, 2015 - 2021
9.2.2.5.5.2. Market Forecast, 2022 - 2030
9.2.3. Retinal Disease Treatment
9.2.3.1.
Definition
9.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.3.3.
Market
Forecast, 2022 - 2030
9.2.3.4.
Compound
Annual Growth Rate (CAGR)
9.2.3.5.
Regional
Bifurcation
9.2.3.5.1.
North America
9.2.3.5.1.1. Market Estimation, 2015 - 2021
9.2.3.5.1.2. Market Forecast, 2022 - 2030
9.2.3.5.2.
Europe
9.2.3.5.2.1. Market Estimation, 2015 - 2021
9.2.3.5.2.2. Market Forecast, 2022 - 2030
9.2.3.5.3.
Asia
Pacific
9.2.3.5.3.1. Market Estimation, 2015 - 2021
9.2.3.5.3.2. Market Forecast, 2022 - 2030
9.2.3.5.4.
Middle
East and Africa
9.2.3.5.4.1. Market Estimation, 2015 - 2021
9.2.3.5.4.2. Market Forecast, 2022 - 2030
9.2.3.5.5.
Latin
America
9.2.3.5.5.1. Market Estimation, 2015 - 2021
9.2.3.5.5.2. Market Forecast, 2022 - 2030
9.2.4. Others
9.2.4.1.
Definition
9.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.4.3.
Market
Forecast, 2022 - 2030
9.2.4.4.
Compound
Annual Growth Rate (CAGR)
9.2.4.5.
Regional
Bifurcation
9.2.4.5.1.
North
America
9.2.4.5.1.1. Market Estimation, 2015 - 2021
9.2.4.5.1.2. Market Forecast, 2022 - 2030
9.2.4.5.2.
Europe
9.2.4.5.2.1. Market Estimation, 2015 - 2021
9.2.4.5.2.2. Market Forecast, 2022 - 2030
9.2.4.5.3.
Asia
Pacific
9.2.4.5.3.1. Market Estimation, 2015 - 2021
9.2.4.5.3.2. Market Forecast, 2022 - 2030
9.2.4.5.4.
Middle
East and Africa
9.2.4.5.4.1. Market Estimation, 2015 - 2021
9.2.4.5.4.2. Market Forecast, 2022 - 2030
9.2.4.5.5.
Latin
America
9.2.4.5.5.1. Market Estimation, 2015 - 2021
9.2.4.5.5.2. Market Forecast, 2022 - 2030
9.3. Key Segment for Channeling Investments
9.3.1. By Application
10. Global Optogenetics Market Analysis and
Forecasts, 2022 - 2030
10.1. Overview
10.2. Global Optogenetics Market Revenue (US$ Mn)
and Forecasts, By End Users
10.2.1. Hospitals and Clinics
10.2.1.1.
Definition
10.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.1.3.
Market
Forecast, 2022 - 2030
10.2.1.4.
Compound
Annual Growth Rate (CAGR)
10.2.1.5.
Regional
Bifurcation
10.2.1.5.1.
North America
10.2.1.5.1.1. Market Estimation, 2015 - 2021
10.2.1.5.1.2. Market Forecast, 2022 - 2030
10.2.1.5.2.
Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2021
10.2.1.5.2.2. Market Forecast, 2022 - 2030
10.2.1.5.3.
Asia
Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2021
10.2.1.5.3.2. Market Forecast, 2022 - 2030
10.2.1.5.4.
Middle
East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2021
10.2.1.5.4.2. Market Forecast, 2022 - 2030
10.2.1.5.5.
Latin
America
10.2.1.5.5.1. Market Estimation, 2015 - 2021
10.2.1.5.5.2. Market Forecast, 2022 - 2030
10.2.2. Diagnostics Centers
10.2.2.1.
Definition
10.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.2.3.
Market
Forecast, 2022 - 2030
10.2.2.4.
Compound
Annual Growth Rate (CAGR)
10.2.2.5.
Regional
Bifurcation
10.2.2.5.1.
North
America
10.2.2.5.1.1. Market Estimation, 2015 - 2021
10.2.2.5.1.2. Market Forecast, 2022 - 2030
10.2.2.5.2.
Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2021
10.2.2.5.2.2. Market Forecast, 2022 - 2030
10.2.2.5.3.
Asia
Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2021
10.2.2.5.3.2. Market Forecast, 2022 - 2030
10.2.2.5.4.
Middle East
and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2021
10.2.2.5.4.2. Market Forecast, 2022 - 2030
10.2.2.5.5.
Latin
America
10.2.2.5.5.1. Market Estimation, 2015 - 2021
10.2.2.5.5.2. Market Forecast, 2022 - 2030
10.2.3. Research Centers
10.2.3.1.
Definition
10.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.3.3.
Market
Forecast, 2022 - 2030
10.2.3.4.
Compound
Annual Growth Rate (CAGR)
10.2.3.5.
Regional
Bifurcation
10.2.3.5.1.
North
America
10.2.3.5.1.1. Market Estimation, 2015 - 2021
10.2.3.5.1.2. Market Forecast, 2022 - 2030
10.2.3.5.2.
Europe
10.2.3.5.2.1. Market Estimation, 2015 - 2021
10.2.3.5.2.2. Market Forecast, 2022 - 2030
10.2.3.5.3.
Asia
Pacific
10.2.3.5.3.1. Market Estimation, 2015 - 2021
10.2.3.5.3.2. Market Forecast, 2022 - 2030
10.2.3.5.4.
Middle
East and Africa
10.2.3.5.4.1. Market Estimation, 2015 - 2021
10.2.3.5.4.2. Market Forecast, 2022 - 2030
10.2.3.5.5.
Latin
America
10.2.3.5.5.1. Market Estimation, 2015 - 2021
10.2.3.5.5.2. Market Forecast, 2022 - 2030
10.2.4. Others
10.2.4.1.
Definition
10.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.4.3.
Market
Forecast, 2022 - 2030
10.2.4.4.
Compound
Annual Growth Rate (CAGR)
10.2.4.5.
Regional
Bifurcation
10.2.4.5.1.
North
America
10.2.4.5.1.1. Market Estimation, 2015 - 2021
10.2.4.5.1.2. Market Forecast, 2022 - 2030
10.2.4.5.2.
Europe
10.2.4.5.2.1. Market Estimation, 2015 - 2021
10.2.4.5.2.2. Market Forecast, 2022 - 2030
10.2.4.5.3.
Asia
Pacific
10.2.4.5.3.1. Market Estimation, 2015 - 2021
10.2.4.5.3.2. Market Forecast, 2022 - 2030
10.2.4.5.4.
Middle
East and Africa
10.2.4.5.4.1. Market Estimation, 2015 - 2021
10.2.4.5.4.2. Market Forecast, 2022 - 2030
10.2.4.5.5.
Latin
America
10.2.4.5.5.1. Market Estimation, 2015 - 2021
10.2.4.5.5.2. Market Forecast, 2022 - 2030
10.3. Key Segment for Channeling Investments
10.3.1. By End Users
11. North America Optogenetics Market Analysis
and Forecasts, 2022 - 2030
11.1. Overview
11.1.1. North America Optogenetics Market Revenue
(US$ Mn)
11.2. North America Optogenetics Market Revenue
(US$ Mn) and Forecasts, By Product Type
11.2.1. Lasers
11.2.2. Sensors
11.2.3. Actuators
11.3. North America Optogenetics Market Revenue
(US$ Mn) and Forecasts, By Application
11.3.1. Neuroscience
11.3.2. Behavioural Tracking
11.3.3. Retinal Disease Treatment
11.3.4. Others
11.4. North America Optogenetics Market Revenue
(US$ Mn) and Forecasts, By End Users
11.4.1. Hospitals and Clinics
11.4.2. Diagnostics Centers
11.4.3. Research Centers
11.4.4. Others
11.5. North America Optogenetics Market Revenue
(US$ Mn) and Forecasts, By Country
11.5.1. U.S
11.5.1.1.
U.S
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
11.5.1.1.1.
Lasers
11.5.1.1.2.
Sensors
11.5.1.1.3.
Actuators
11.5.1.2.
U.S
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
11.5.1.2.1.
Neuroscience
11.5.1.2.2.
Behavioural
Tracking
11.5.1.2.3.
Retinal
Disease Treatment
11.5.1.2.4.
Others
11.5.1.3.
U.S
Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
11.5.1.3.1.
Hospitals
and Clinics
11.5.1.3.2.
Diagnostics
Centers
11.5.1.3.3.
Research
Centers
11.5.1.3.4.
Others
11.5.2. Canada
11.5.2.1.
Canada
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
11.5.2.1.1.
Lasers
11.5.2.1.2.
Sensors
11.5.2.1.3.
Actuators
11.5.2.2.
Canada
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
11.5.2.2.1.
Neuroscience
11.5.2.2.2.
Behavioural
Tracking
11.5.2.2.3.
Retinal
Disease Treatment
11.5.2.2.4.
Others
11.5.2.3.
Canada
Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
11.5.2.3.1.
Hospitals
and Clinics
11.5.2.3.2.
Diagnostics
Centers
11.5.2.3.3.
Research
Centers
11.5.2.3.4.
Others
11.5.3. Mexico
11.5.3.1.
Mexico
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
11.5.3.1.1.
Lasers
11.5.3.1.2.
Sensors
11.5.3.1.3.
Actuators
11.5.3.2.
Mexico
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
11.5.3.2.1.
Neuroscience
11.5.3.2.2.
Behavioural
Tracking
11.5.3.2.3.
Retinal
Disease Treatment
11.5.3.2.4.
Others
11.5.3.3.
Mexico
Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
11.5.3.3.1.
Hospitals
and Clinics
11.5.3.3.2.
Diagnostics
Centers
11.5.3.3.3.
Research
Centers
11.5.3.3.4.
Others
11.5.4. Rest of North America
11.5.4.1.
Rest of
North America Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product
Type
11.5.4.1.1.
Lasers
11.5.4.1.2.
Sensors
11.5.4.1.3.
Actuators
11.5.4.2.
Rest of
North America Optogenetics Market Revenue (US$ Mn) and Forecasts, By
Application
11.5.4.2.1.
Neuroscience
11.5.4.2.2.
Behavioural
Tracking
11.5.4.2.3.
Retinal
Disease Treatment
11.5.4.2.4.
Others
11.5.4.3.
Rest of
North America Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
11.5.4.3.1.
Hospitals
and Clinics
11.5.4.3.2.
Diagnostics
Centers
11.5.4.3.3.
Research
Centers
11.5.4.3.4.
Others
11.6. Key Segment for Channeling Investments
11.6.1. By Country
11.6.2. By Product Type
11.6.3. By Application
11.6.4. By End Users
12. Europe Optogenetics Market Analysis and
Forecasts, 2022 - 2030
12.1. Overview
12.1.1. Europe Optogenetics Market Revenue (US$ Mn)
12.2. Europe Optogenetics Market Revenue (US$ Mn)
and Forecasts, By Product Type
12.2.1. Lasers
12.2.2. Sensors
12.2.3. Actuators
12.3. Europe Optogenetics Market Revenue (US$ Mn)
and Forecasts, By Application
12.3.1. Neuroscience
12.3.2. Behavioural Tracking
12.3.3. Retinal Disease Treatment
12.3.4. Others
12.4. Europe Optogenetics Market Revenue (US$ Mn)
and Forecasts, By End Users
12.4.1. Hospitals and Clinics
12.4.2. Diagnostics Centers
12.4.3. Research Centers
12.4.4. Others
12.5. Europe Optogenetics Market Revenue (US$ Mn)
and Forecasts, By Country
12.5.1. France
12.5.1.1.
France
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.1.1.1.
Lasers
12.5.1.1.2.
Sensors
12.5.1.1.3.
Actuators
12.5.1.2.
France
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
12.5.1.2.1.
Neuroscience
12.5.1.2.2.
Behavioural
Tracking
12.5.1.2.3.
Retinal
Disease Treatment
12.5.1.2.4.
Others
12.5.1.3.
France
Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.1.3.1.
Hospitals
and Clinics
12.5.1.3.2.
Diagnostics
Centers
12.5.1.3.3.
Research
Centers
12.5.1.3.4.
Others
12.5.2. The UK
12.5.2.1.
The UK
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.2.1.1.
Lasers
12.5.2.1.2.
Sensors
12.5.2.1.3.
Actuators
12.5.2.2.
The UK
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
12.5.2.2.1.
Neuroscience
12.5.2.2.2.
Behavioural
Tracking
12.5.2.2.3.
Retinal
Disease Treatment
12.5.2.2.4.
Others
12.5.2.3.
The UK
Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.2.3.1.
Hospitals
and Clinics
12.5.2.3.2.
Diagnostics
Centers
12.5.2.3.3.
Research
Centers
12.5.2.3.4.
Others
12.5.3. Spain
12.5.3.1.
Spain
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.3.1.1.
Lasers
12.5.3.1.2.
Sensors
12.5.3.1.3.
Actuators
12.5.3.2.
Spain
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
12.5.3.2.1.
Neuroscience
12.5.3.2.2.
Behavioural
Tracking
12.5.3.2.3.
Retinal
Disease Treatment
12.5.3.2.4.
Others
12.5.3.3.
Spain
Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.3.3.1.
Hospitals
and Clinics
12.5.3.3.2.
Diagnostics
Centers
12.5.3.3.3.
Research
Centers
12.5.3.3.4.
Others
12.5.4. Germany
12.5.4.1.
Germany
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.4.1.1.
Lasers
12.5.4.1.2.
Sensors
12.5.4.1.3.
Actuators
12.5.4.2.
Germany
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
12.5.4.2.1.
Neuroscience
12.5.4.2.2.
Behavioural
Tracking
12.5.4.2.3.
Retinal
Disease Treatment
12.5.4.2.4.
Others
12.5.4.3.
Germany
Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.4.3.1.
Hospitals
and Clinics
12.5.4.3.2.
Diagnostics
Centers
12.5.4.3.3.
Research
Centers
12.5.4.3.4.
Others
12.5.5. Italy
12.5.5.1.
Italy
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.5.1.1.
Lasers
12.5.5.1.2.
Sensors
12.5.5.1.3.
Actuators
12.5.5.2.
Italy
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
12.5.5.2.1.
Neuroscience
12.5.5.2.2.
Behavioural
Tracking
12.5.5.2.3.
Retinal
Disease Treatment
12.5.5.2.4.
Others
12.5.5.3.
Italy
Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.5.3.1.
Hospitals
and Clinics
12.5.5.3.2.
Diagnostics
Centers
12.5.5.3.3.
Research
Centers
12.5.5.3.4.
Others
12.5.6. Nordic Countries
12.5.6.1.
Nordic
Countries Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.6.1.1.
Lasers
12.5.6.1.2.
Sensors
12.5.6.1.3.
Actuators
12.5.6.2.
Nordic
Countries Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
12.5.6.2.1.
Neuroscience
12.5.6.2.2.
Behavioural
Tracking
12.5.6.2.3.
Retinal
Disease Treatment
12.5.6.2.4.
Others
12.5.6.3.
Nordic
Countries Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.6.3.1.
Hospitals
and Clinics
12.5.6.3.2.
Diagnostics
Centers
12.5.6.3.3.
Research
Centers
12.5.6.3.4.
Others
12.5.6.4.
Nordic
Countries Optogenetics Market Revenue (US$ Mn) and Forecasts, By Country
12.5.6.4.1.
Denmark
12.5.6.4.2.
Finland
12.5.6.4.3.
Iceland
12.5.6.4.4.
Sweden
12.5.6.4.5.
Norway
12.5.7. Benelux Union
12.5.7.1.
Benelux
Union Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.7.1.1.
Lasers
12.5.7.1.2.
Sensors
12.5.7.1.3.
Actuators
12.5.7.2.
Benelux
Union Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
12.5.7.2.1.
Neuroscience
12.5.7.2.2.
Behavioural
Tracking
12.5.7.2.3.
Retinal
Disease Treatment
12.5.7.2.4.
Others
12.5.7.3.
Benelux
Union Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.7.3.1.
Hospitals
and Clinics
12.5.7.3.2.
Diagnostics
Centers
12.5.7.3.3.
Research
Centers
12.5.7.3.4.
Others
12.5.7.4.
Benelux
Union Optogenetics Market Revenue (US$ Mn) and Forecasts, By Country
12.5.7.4.1.
Belgium
12.5.7.4.2.
The
Netherlands
12.5.7.4.3.
Luxembourg
12.5.8. Rest of Europe
12.5.8.1.
Rest of
Europe Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
12.5.8.1.1.
Lasers
12.5.8.1.2.
Sensors
12.5.8.1.3.
Actuators
12.5.8.2.
Rest of
Europe Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
12.5.8.2.1.
Neuroscience
12.5.8.2.2.
Behavioural
Tracking
12.5.8.2.3.
Retinal
Disease Treatment
12.5.8.2.4.
Others
12.5.8.3.
Rest of
Europe Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.8.3.1.
Hospitals
and Clinics
12.5.8.3.2.
Diagnostics
Centers
12.5.8.3.3.
Research
Centers
12.5.8.3.4.
Others
12.6. Key Segment for Channeling Investments
12.6.1. By Country
12.6.2. By Product Type
12.6.3. By Application
12.6.4. By End Users
13. Asia Pacific Optogenetics Market Analysis
and Forecasts, 2022 - 2030
13.1. Overview
13.1.1. Asia Pacific Optogenetics Market Revenue (US$
Mn)
13.2. Asia Pacific Optogenetics Market Revenue (US$
Mn) and Forecasts, By Product Type
13.2.1. Lasers
13.2.2. Sensors
13.2.3. Actuators
13.3. Asia Pacific Optogenetics Market Revenue (US$
Mn) and Forecasts, By Application
13.3.1. Neuroscience
13.3.2. Behavioural Tracking
13.3.3. Retinal Disease Treatment
13.3.4. Others
13.4. Asia Pacific Optogenetics Market Revenue (US$
Mn) and Forecasts, By End Users
13.4.1. Hospitals and Clinics
13.4.2. Diagnostics Centers
13.4.3. Research Centers
13.4.4. Others
13.5. Asia Pacific Optogenetics Market Revenue (US$
Mn) and Forecasts, By Country
13.5.1. China
13.5.1.1.
China
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.1.1.1.
Lasers
13.5.1.1.2.
Sensors
13.5.1.1.3.
Actuators
13.5.1.2.
China
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
13.5.1.2.1.
Neuroscience
13.5.1.2.2.
Behavioural
Tracking
13.5.1.2.3.
Retinal
Disease Treatment
13.5.1.2.4.
Others
13.5.1.3.
China
Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.1.3.1.
Hospitals
and Clinics
13.5.1.3.2.
Diagnostics
Centers
13.5.1.3.3.
Research
Centers
13.5.1.3.4.
Others
13.5.2. Japan
13.5.2.1.
Japan
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.2.1.1.
Lasers
13.5.2.1.2.
Sensors
13.5.2.1.3.
Actuators
13.5.2.2.
Japan
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
13.5.2.2.1.
Neuroscience
13.5.2.2.2.
Behavioural
Tracking
13.5.2.2.3.
Retinal
Disease Treatment
13.5.2.2.4.
Others
13.5.2.3.
Japan
Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.2.3.1.
Hospitals
and Clinics
13.5.2.3.2.
Diagnostics
Centers
13.5.2.3.3.
Research
Centers
13.5.2.3.4.
Others
13.5.3. India
13.5.3.1.
India
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.3.1.1.
Lasers
13.5.3.1.2.
Sensors
13.5.3.1.3.
Actuators
13.5.3.2.
India
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
13.5.3.2.1.
Neuroscience
13.5.3.2.2.
Behavioural
Tracking
13.5.3.2.3.
Retinal
Disease Treatment
13.5.3.2.4.
Others
13.5.3.3.
India
Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.3.3.1.
Hospitals
and Clinics
13.5.3.3.2.
Diagnostics
Centers
13.5.3.3.3.
Research
Centers
13.5.3.3.4.
Others
13.5.4. New Zealand
13.5.4.1.
New
Zealand Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.4.1.1.
Lasers
13.5.4.1.2.
Sensors
13.5.4.1.3.
Actuators
13.5.4.2.
New
Zealand Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
13.5.4.2.1.
Neuroscience
13.5.4.2.2.
Behavioural
Tracking
13.5.4.2.3.
Retinal
Disease Treatment
13.5.4.2.4.
Others
13.5.4.3.
New
Zealand Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.4.3.1.
Hospitals
and Clinics
13.5.4.3.2.
Diagnostics
Centers
13.5.4.3.3.
Research
Centers
13.5.4.3.4.
Others
13.5.5. Australia
13.5.5.1.
Australia
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.5.1.1.
Lasers
13.5.5.1.2.
Sensors
13.5.5.1.3.
Actuators
13.5.5.2.
Australia
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
13.5.5.2.1.
Neuroscience
13.5.5.2.2.
Behavioural
Tracking
13.5.5.2.3.
Retinal
Disease Treatment
13.5.5.2.4.
Others
13.5.5.3.
Australia
Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.5.3.1.
Hospitals
and Clinics
13.5.5.3.2.
Diagnostics
Centers
13.5.5.3.3.
Research
Centers
13.5.5.3.4.
Others
13.5.6. South Korea
13.5.6.1.
South
Korea Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.6.1.1.
Lasers
13.5.6.1.2.
Sensors
13.5.6.1.3.
Actuators
13.5.6.2.
South
Korea Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
13.5.6.2.1.
Neuroscience
13.5.6.2.2.
Behavioural
Tracking
13.5.6.2.3.
Retinal
Disease Treatment
13.5.6.2.4.
Others
13.5.6.3.
South
Korea Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.6.3.1.
Hospitals
and Clinics
13.5.6.3.2.
Diagnostics
Centers
13.5.6.3.3.
Research
Centers
13.5.6.3.4.
Others
13.5.7. Southeast Asia
13.5.7.1.
Southeast
Asia Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
13.5.7.1.1.
Lasers
13.5.7.1.2.
Sensors
13.5.7.1.3.
Actuators
13.5.7.2.
Southeast
Asia Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
13.5.7.2.1.
Neuroscience
13.5.7.2.2.
Behavioural
Tracking
13.5.7.2.3.
Retinal
Disease Treatment
13.5.7.2.4.
Others
13.5.7.3.
Southeast
Asia Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.7.3.1.
Hospitals
and Clinics
13.5.7.3.2.
Diagnostics
Centers
13.5.7.3.3.
Research
Centers
13.5.7.3.4.
Others
13.5.7.4.
Southeast
Asia Optogenetics Market Revenue (US$ Mn) and Forecasts, By Country
13.5.7.4.1.
Indonesia
13.5.7.4.2.
Thailand
13.5.7.4.3.
Malaysia
13.5.7.4.4.
Singapore
13.5.7.4.5.
Rest of
Southeast Asia
13.5.8. Rest of Asia Pacific
13.5.8.1.
Rest of
Asia Pacific Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product
Type
13.5.8.1.1.
Lasers
13.5.8.1.2.
Sensors
13.5.8.1.3.
Actuators
13.5.8.2.
Rest of
Asia Pacific Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
13.5.8.2.1.
Neuroscience
13.5.8.2.2.
Behavioural
Tracking
13.5.8.2.3.
Retinal
Disease Treatment
13.5.8.2.4.
Others
13.5.8.3.
Rest of
Asia Pacific Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.8.3.1.
Hospitals
and Clinics
13.5.8.3.2.
Diagnostics
Centers
13.5.8.3.3.
Research
Centers
13.5.8.3.4.
Others
13.6. Key Segment for Channeling Investments
13.6.1. By Country
13.6.2. By Product Type
13.6.3. By Application
13.6.4. By End Users
14. Middle East and Africa Optogenetics Market
Analysis and Forecasts, 2022 - 2030
14.1. Overview
14.1.1. Middle East and Africa Optogenetics Market
Revenue (US$ Mn)
14.2. Middle East and Africa Optogenetics Market
Revenue (US$ Mn) and Forecasts, By Product Type
14.2.1. Lasers
14.2.2. Sensors
14.2.3. Actuators
14.3. Middle East and Africa Optogenetics Market
Revenue (US$ Mn) and Forecasts, By Application
14.3.1. Neuroscience
14.3.2. Behavioural Tracking
14.3.3. Retinal Disease Treatment
14.3.4. Others
14.4. Middle East and Africa Optogenetics Market
Revenue (US$ Mn) and Forecasts, By End Users
14.4.1. Hospitals and Clinics
14.4.2. Diagnostics Centers
14.4.3. Research Centers
14.4.4. Others
14.5. Middle East and Africa Optogenetics Market
Revenue (US$ Mn) and Forecasts, By Country
14.5.1. Saudi Arabia
14.5.1.1.
Saudi
Arabia Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
14.5.1.1.1.
Lasers
14.5.1.1.2.
Sensors
14.5.1.1.3.
Actuators
14.5.1.2.
Saudi
Arabia Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
14.5.1.2.1.
Neuroscience
14.5.1.2.2.
Behavioural
Tracking
14.5.1.2.3.
Retinal
Disease Treatment
14.5.1.2.4.
Others
14.5.1.3.
Saudi
Arabia Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.1.3.1.
Hospitals
and Clinics
14.5.1.3.2.
Diagnostics
Centers
14.5.1.3.3.
Research
Centers
14.5.1.3.4.
Others
14.5.2. UAE
14.5.2.1.
UAE
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
14.5.2.1.1.
Lasers
14.5.2.1.2.
Sensors
14.5.2.1.3.
Actuators
14.5.2.2.
UAE
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
14.5.2.2.1.
Neuroscience
14.5.2.2.2.
Behavioural
Tracking
14.5.2.2.3.
Retinal
Disease Treatment
14.5.2.2.4.
Others
14.5.2.3.
UAE
Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.2.3.1.
Hospitals
and Clinics
14.5.2.3.2.
Diagnostics
Centers
14.5.2.3.3.
Research
Centers
14.5.2.3.4.
Others
14.5.3. Egypt
14.5.3.1.
Egypt
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
14.5.3.1.1.
Lasers
14.5.3.1.2.
Sensors
14.5.3.1.3.
Actuators
14.5.3.2.
Egypt
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
14.5.3.2.1.
Neuroscience
14.5.3.2.2.
Behavioural
Tracking
14.5.3.2.3.
Retinal
Disease Treatment
14.5.3.2.4.
Others
14.5.3.3.
Egypt
Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.3.3.1.
Hospitals
and Clinics
14.5.3.3.2.
Diagnostics
Centers
14.5.3.3.3.
Research
Centers
14.5.3.3.4.
Others
14.5.4. Kuwait
14.5.4.1.
Kuwait
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
14.5.4.1.1.
Lasers
14.5.4.1.2.
Sensors
14.5.4.1.3.
Actuators
14.5.4.2.
Kuwait
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
14.5.4.2.1.
Neuroscience
14.5.4.2.2.
Behavioural
Tracking
14.5.4.2.3.
Retinal
Disease Treatment
14.5.4.2.4.
Others
14.5.4.3.
Kuwait
Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.4.3.1.
Hospitals
and Clinics
14.5.4.3.2.
Diagnostics
Centers
14.5.4.3.3.
Research
Centers
14.5.4.3.4.
Others
14.5.5. South Africa
14.5.5.1.
South
Africa Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
14.5.5.1.1.
Lasers
14.5.5.1.2.
Sensors
14.5.5.1.3.
Actuators
14.5.5.2.
South
Africa Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
14.5.5.2.1.
Neuroscience
14.5.5.2.2.
Behavioural
Tracking
14.5.5.2.3.
Retinal
Disease Treatment
14.5.5.2.4.
Others
14.5.5.3.
South
Africa Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.5.3.1.
Hospitals
and Clinics
14.5.5.3.2.
Diagnostics
Centers
14.5.5.3.3.
Research
Centers
14.5.5.3.4.
Others
14.5.6. Rest of Middle East & Africa
14.5.6.1.
Rest of
Middle East & Africa Optogenetics Market Revenue (US$ Mn) and Forecasts, By
Product Type
14.5.6.1.1.
Lasers
14.5.6.1.2.
Sensors
14.5.6.1.3.
Actuators
14.5.6.2.
Rest of
Middle East & Africa Optogenetics Market Revenue (US$ Mn) and Forecasts, By
Application
14.5.6.2.1.
Neuroscience
14.5.6.2.2.
Behavioural
Tracking
14.5.6.2.3.
Retinal
Disease Treatment
14.5.6.2.4.
Others
14.5.6.3.
Rest of
Middle East & Africa Optogenetics Market Revenue (US$ Mn) and Forecasts, By
End Users
14.5.6.3.1.
Hospitals
and Clinics
14.5.6.3.2.
Diagnostics
Centers
14.5.6.3.3.
Research
Centers
14.5.6.3.4.
Others
14.6. Key Segment for Channeling Investments
14.6.1. By Country
14.6.2. By Product Type
14.6.3. By Application
14.6.4. By End Users
15. Latin America Optogenetics Market Analysis
and Forecasts, 2022 - 2030
15.1. Overview
15.1.1. Latin America Optogenetics Market Revenue
(US$ Mn)
15.2. Latin America Optogenetics Market Revenue
(US$ Mn) and Forecasts, By Product Type
15.2.1. Lasers
15.2.2. Sensors
15.2.3. Actuators
15.3. Latin America Optogenetics Market Revenue
(US$ Mn) and Forecasts, By Application
15.3.1. Neuroscience
15.3.2. Behavioural Tracking
15.3.3. Retinal Disease Treatment
15.3.4. Others
15.4. Latin America Optogenetics Market Revenue
(US$ Mn) and Forecasts, By End Users
15.4.1. Hospitals and Clinics
15.4.2. Diagnostics Centers
15.4.3. Research Centers
15.4.4. Others
15.5. Latin America Optogenetics Market Revenue
(US$ Mn) and Forecasts, By Country
15.5.1. Brazil
15.5.1.1.
Brazil Optogenetics
Market Revenue (US$ Mn) and Forecasts, By Product Type
15.5.1.1.1.
Lasers
15.5.1.1.2.
Sensors
15.5.1.1.3.
Actuators
15.5.1.2.
Brazil
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
15.5.1.2.1.
Neuroscience
15.5.1.2.2.
Behavioural
Tracking
15.5.1.2.3.
Retinal
Disease Treatment
15.5.1.2.4.
Others
15.5.1.3.
Brazil
Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.1.3.1.
Hospitals
and Clinics
15.5.1.3.2.
Diagnostics
Centers
15.5.1.3.3.
Research
Centers
15.5.1.3.4.
Others
15.5.2. Argentina
15.5.2.1.
Argentina
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product Type
15.5.2.1.1.
Lasers
15.5.2.1.2.
Sensors
15.5.2.1.3.
Actuators
15.5.2.2.
Argentina
Optogenetics Market Revenue (US$ Mn) and Forecasts, By Application
15.5.2.2.1.
Neuroscience
15.5.2.2.2.
Behavioural
Tracking
15.5.2.2.3.
Retinal
Disease Treatment
15.5.2.2.4.
Others
15.5.2.3.
Argentina
Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.2.3.1.
Hospitals
and Clinics
15.5.2.3.2.
Diagnostics
Centers
15.5.2.3.3.
Research
Centers
15.5.2.3.4.
Others
15.5.3. Rest of Latin America
15.5.3.1.
Rest of
Latin America Optogenetics Market Revenue (US$ Mn) and Forecasts, By Product
Type
15.5.3.1.1.
Lasers
15.5.3.1.2.
Sensors
15.5.3.1.3.
Actuators
15.5.3.2.
Rest of
Latin America Optogenetics Market Revenue (US$ Mn) and Forecasts, By
Application
15.5.3.2.1.
Neuroscience
15.5.3.2.2.
Behavioural
Tracking
15.5.3.2.3.
Retinal
Disease Treatment
15.5.3.2.4.
Others
15.5.3.3.
Rest of
Latin America Optogenetics Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.3.3.1.
Hospitals
and Clinics
15.5.3.3.2.
Diagnostics
Centers
15.5.3.3.3.
Research
Centers
15.5.3.3.4.
Others
15.6. Key Segment for Channeling Investments
15.6.1. By Country
15.6.2. By Product Type
15.6.3. By Application
15.6.4. By End Users
16. Competitive Benchmarking
16.1. Brand Benchmarking
16.2. Market Share Analysis, 2021
16.3. Global Presence and Growth Strategies
16.3.1. Mergers and Acquisitions
16.3.2. Product Launches
16.3.3. Investments Trends
16.3.4. R&D Initiatives
17. Player Profiles
17.1. Bruker
17.1.1. Company Details
17.1.2. Company Overview
17.1.3. Product Offerings
17.1.4. Key Developments
17.1.5. Financial Analysis
17.1.6. SWOT Analysis
17.1.7. Business Strategies
17.2. Campden Instruments
17.2.1. Company Details
17.2.2. Company Overview
17.2.3. Product Offerings
17.2.4. Key Developments
17.2.5. Financial Analysis
17.2.6. SWOT Analysis
17.2.7. Business Strategies
17.3. Coherent, Inc
17.3.1. Company Details
17.3.2. Company Overview
17.3.3. Product Offerings
17.3.4. Key Developments
17.3.5. Financial Analysis
17.3.6. SWOT Analysis
17.3.7. Business Strategies
17.4. Elliot Scientific Ltd.
17.4.1. Company Details
17.4.2. Company Overview
17.4.3. Product Offerings
17.4.4. Key Developments
17.4.5. Financial Analysis
17.4.6. SWOT Analysis
17.4.7. Business Strategies
17.5. Gensight Biologics
17.5.1. Company Details
17.5.2. Company Overview
17.5.3. Product Offerings
17.5.4. Key Developments
17.5.5. Financial Analysis
17.5.6. SWOT Analysis
17.5.7. Business Strategies
17.6. Judges Scientific plc
17.6.1. Company Details
17.6.2. Company Overview
17.6.3. Product Offerings
17.6.4. Key Developments
17.6.5. Financial Analysis
17.6.6. SWOT Analysis
17.6.7. Business Strategies
17.7. Merck KGaA
17.7.1. Company Details
17.7.2. Company Overview
17.7.3. Product Offerings
17.7.4. Key Developments
17.7.5. Financial Analysis
17.7.6. SWOT Analysis
17.7.7. Business Strategies
17.8. Nanoscope Therapeutics, Inc.
17.8.1. Company Details
17.8.2. Company Overview
17.8.3. Product Offerings
17.8.4. Key Developments
17.8.5. Financial Analysis
17.8.6. SWOT Analysis
17.8.7. Business Strategies
17.9. Noldus Information Technology
17.9.1. Company Details
17.9.2. Company Overview
17.9.3. Product Offerings
17.9.4. Key Developments
17.9.5. Financial Analysis
17.9.6. SWOT Analysis
17.9.7. Business Strategies
17.10. Prizmatix
17.10.1. Company Details
17.10.2. Company Overview
17.10.3. Product Offerings
17.10.4. Key Developments
17.10.5. Financial Analysis
17.10.6. SWOT Analysis
17.10.7. Business Strategies
17.11. Scientifica
17.11.1. Company Details
17.11.2. Company Overview
17.11.3. Product Offerings
17.11.4. Key Developments
17.11.5. Financial Analysis
17.11.6. SWOT Analysis
17.11.7. Business Strategies
17.12. Thorlabs, Inc.
17.12.1. Company Details
17.12.2. Company Overview
17.12.3. Product Offerings
17.12.4. Key Developments
17.12.5. Financial Analysis
17.12.6. SWOT Analysis
17.12.7. Business Strategies
17.13. Other Market Participants
18. Key Findings
Note: This ToC is tentative and
can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.